Showing results (391-400 of 496) with videos related to

Sort By:
Pageof 50
The Journal of Experimental Biology|July 22, 2025
Microbiome composition shapes temperature tolerance in a Hawaiian picture-winged DrosophilaDonald K Price, Kristian West, Michelle Cevallos-Zea, et al.
BJU International|June 10, 2008
A polymorphism in a transporter of testosterone is a determinant of androgen independence in prostate cancerNima Sharifi, Akinobu Hamada, Tristan Sissung, et al.
Molecular Pharmacology|April 2, 2015
Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cellsElena V Fernandez, Kelie M Reece, Ariel M Ley, et al.
Scientific Reports|May 25, 2021
Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3pRoberto H Barbier, Edel M McCrea, Kristi Y Lee, et al.
Therapeutics and Clinical Risk Management|December 15, 2010
A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancerBevin C English, Caitlin E Baum, David E Adelberg, et al.
Texas Heart Institute Journal|January 1, 1995
Heart transplantation in an 8-month-old girl. 10th anniversary reportO H Frazier, O U Okereke, B Radovancĕvić, et al.
BMJ Open|January 8, 2013
Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?Rui Gao, Kelie M Reece, Tristan Sissung, et al.
International Journal of Molecular Sciences|September 13, 2025
Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian CancerRiya Khetan, Noor A Lokman, Preethi Eldi, et al.
Cancer Investigation|December 7, 2000
The phosphoprotein Op18/stathmin is differentially expressed in ovarian cancerD K Price, J R Ball, Z Bahrani-Mostafavi, et al.
The Prostate|November 26, 2009
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention TrialAlan R Kristal, Douglas K Price, Cathee Till, et al.
Pageof 50